HIV wasting syndrome: treatment update (Q41751382)

8 October 2017

1 reference

title

HIV wasting syndrome: treatment update (English)

1 reference

8 October 2017

1 reference

D L Balog

1

1 reference

8 October 2017

M E Epstein

series ordinal

2

1 reference

8 October 2017

M I Amodio-Groton

series ordinal

3

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Annals of Pharmacotherapy

8 October 2017

1 reference

8 October 2017

32

1 reference

8 October 2017

4

1 reference

8 October 2017

446-458

1 reference

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

8 October 2017

1 reference

Metabolic disturbances and wasting in the acquired immunodeficiency syndrome

21 January 2018

1 reference

Increased resting energy expenditure in human immunodeficiency virus-infected men.

21 January 2018

1 reference

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

Energy expenditure and wasting in human immunodeficiency virus infection

21 January 2018

1 reference

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

HIV disease and the endocrine system

21 January 2018

1 reference

Endocrine disorders in men infected with human immunodeficiency virus

21 January 2018

1 reference

Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

Catabolic illness. Strategies for enhancing recovery

21 January 2018

1 reference

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

21 January 2018

1 reference

Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome

21 January 2018

1 reference

HIV-associated diarrhoea and wasting.

21 January 2018

1 reference

Combating malnutrition in HIV infection

21 January 2018

1 reference

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

21 January 2018

1 reference

Genetic polymorphism of envelope V3 region of HIV type 1 subtypes A, C, and D from Nairobi, Kenya

21 January 2018

1 reference

Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users

21 January 2018

1 reference

Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Evidence for adrenocortical adaptation to severe illness

21 January 2018

1 reference

Plasma dehydroepiandrosterone levels in HIV infection

21 January 2018

1 reference

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

21 January 2018

1 reference

Recent clinical experience with dronabinol

21 January 2018

1 reference

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

21 January 2018

1 reference

Marijuana, the AIDS wasting syndrome, and the U.S. government.

21 January 2018

1 reference

Health consequences of acute and chronic marihuana use.

21 January 2018

1 reference

Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

Megestrol acetate and cachexia associated with human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

Megestrol acetate in patients with AIDS and cachexia

21 January 2018

1 reference

Induction of adrenal suppression by megestrol acetate in patients with AIDS.

21 January 2018

1 reference

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

21 January 2018

1 reference

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

21 January 2018

1 reference

Tumors secreting human TNF/cachectin induce cachexia in mice

21 January 2018

1 reference

Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection

21 January 2018

1 reference

Plasma fatty acid levels in patients with acquired immune deficiency syndrome and in controls

21 January 2018

1 reference

Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production

21 January 2018

1 reference

N-acetylcysteine inhibits latent HIV expression in chronically infected cells

21 January 2018

1 reference

N-acetylcysteine: a new approach to anti-HIV therapy

21 January 2018

1 reference

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

21 January 2018

1 reference

Responses to sustained use of anabolic steroid

21 January 2018

1 reference

Effects of androgenic-anabolic steroids on neuromuscular power and body composition.

21 January 2018

1 reference

Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

21 January 2018

1 reference

An investigation of immunological subclass function in burned adults

21 January 2018

1 reference

The effects of human growth hormone administration in elderly adults with recent weight loss

21 January 2018

1 reference

Biosynthetic human growth hormone in burned patients: a pilot study.

21 January 2018

1 reference

Effects of human growth hormone in men over 60 years old

21 January 2018

1 reference

Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

21 January 2018

1 reference

Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections

21 January 2018

1 reference

Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage

21 January 2018

1 reference

Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

21 January 2018

1 reference

Thyroid function in the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system

21 January 2018

1 reference

Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

21 January 2018

1 reference

Cannabis and cancer chemotherapy. A comparison of oral delta-9-thc and prochlorperazine

21 January 2018

1 reference

Effect of dronabinol on nutritional status in HIV infection

21 January 2018

1 reference

Behavioral analysis of marijuana effects on food intake in humans

21 January 2018

1 reference

Megestrol acetate therapy for advanced breast cancer

21 January 2018

1 reference

Megestrol acetate in patients with AIDS-related cachexia

21 January 2018

1 reference

Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis

21 January 2018

1 reference

Thalidomide for graft-versus-host disease

21 January 2018

1 reference

Thalidomide in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

21 January 2018

1 reference

Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery

21 January 2018

1 reference

Use of human growth hormone combined with nutritional support in a critical care unit

21 January 2018

1 reference

Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients

21 January 2018

1 reference

Effects of recombinant human growth hormone on donor-site healing in severely burned children

21 January 2018

1 reference

Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.17072

1 reference

8 October 2017

1 reference